𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation

✍ Scribed by Madelaine M. Wohlreich; Craig H. Mallinckrodt; Apurva Prakash; John G. Watkin; William P. Carter

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
283 KB
Volume
24
Category
Article
ISSN
1091-4269

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The combination of duloxetine and buprop
The combination of duloxetine and bupropion for treatment-resistant major depressive disorder
✍ George I. Papakostas; John J. Worthington III; Dan V. Iosifescu; Gustavo Kinrys; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 1 views

Our objective was to assess the effectiveness and safety of the combination of duloxetine and bupropion for treatment-resistant major depressive disorder (TRD). A retrospective chart review was conducted to identify patients with major depressive disorder (MDD) who had not experienced full remission

Safety and tolerability of duloxetine in
Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials
✍ James I. Hudson; Madelaine M. Wohlreich; Daniel K. Kajdasz; Craig H. Mallinckrod πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 185 KB πŸ‘ 1 views

## Abstract ## Objective To examine the safety and tolerability of the antidepressant duloxetine across multiple studies for major depressive disorder (MDD). ## Method Safety data were integrated from the acute phases of eight double‐blind, placebo‐controlled trials in which patients were random

A double-blind, multicenter trial compar
A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder
✍ Lesley M. Arnold; Yili Lu; Leslie J. Crofford; Madelaine Wohlreich; Michael J. D πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

## Abstract ## Objective To assess the efficacy and safety of duloxetine, a serotonin and norepinephrine reuptake inhibitor, in subjects with primary fibromyalgia, with or without current major depressive disorder. ## Methods This study was a randomized, double‐blind, placebo‐controlled trial co